All MeV-15 articles
-
NewsFirm advances measles antibodies toward clinical development
Researchers have identified two potent human monoclonal antibodies that could become the first antibody-based therapy for measles. The antibodies strongly neutralized the virus in laboratory studies and animal models, offering a potential new option for vulnerable people who cannot safely receive or fully benefit from vaccination.